LyondellBasell Industries may be undervalued with poor growth indicators, but the 24 analysts following the company give it an rating of hold. Their target prices range from $75.0 to $130.0 per share, for an average of $98.36. At today's price of $93.54, LyondellBasell Industries NV is trading -4.9% away from its average target price, suggesting there is an analyst consensus of some upside potential for the stock.
LyondellBasell Industries operates as a chemical company in the United States, Germany, Mexico, Italy, Poland, France, Japan, China, the Netherlands, and internationally. Based in Houston, TX, the large-cap Industrials company has 19,300 full time employees. LyondellBasell Industries NV has provided a 4.9% dividend yield over the last 12 months.
LyondellBasell Industries has a trailing twelve month P/E ratio of 8.0, compared to an average of 20.49 for the Industrials sector. Based on its EPS guidance of 10.59, the company has a forward P/E ratio of 8.8.
The average compound growth rate of the company's historical and projected earnings per share is 2.0%. On this basis, the company's PEG ratio is 3.96, which suggests that it is overpriced.
On the other hand, the market is potentially undervaluing LyondellBasell Industries NV in terms of its book value because its P/B ratio is 2.4. In comparison, the sector average P/B ratio is 3.78. The company's shares are currently -2.5% below their Graham number, indicating that its shares have a margin of safety.
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Revenue (MM) | $34,727 | $27,753 | $46,173 | $50,451 |
| Revenue Growth | n/a | -20.08% | 66.37% | 9.27% |
| Gross Margins | 15.6% | 12.2% | 19.0% | 13.1% |
| Gross Margins Growth | n/a | -21.79% | 55.74% | -31.05% |
| Operating Margins | 11.8% | 7.7% | 16.0% | 10.2% |
| Operating Margins Growth | n/a | -34.75% | 107.79% | -36.25% |
| Net Margins | 9.76% | 5.12% | 12.12% | 7.69% |
| Net Margins Growth | n/a | -47.54% | 136.72% | -36.55% |
| Earnings Per Share | $9.58 | $4.24 | $16.75 | $11.66 |
| EPS Growth | n/a | -55.74% | 295.05% | -30.39% |
| Diluted Shares (MM) | 353 | 334 | 334 | 326 |
| Free Cash Flow (MM) | $2,267 | $1,457 | $5,736 | $4,229 |
| FCF Growth | n/a | -35.73% | 293.69% | -26.27% |
| Capital Expenditures (MM) | -$2,694 | -$1,947 | -$1,959 | -$1,890 |
| Net Debt / EBITDA | 2.02 | 4.43 | 1.21 | 1.51 |
